Supplementary Table S1 from Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

crossref(2023)

引用 0|浏览11
暂无评分
摘要

Supplementary Table S1. FDA approved HER2-targeted therapies

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要